Fundraising FoxRex Health Ventures — Full Portfolio
28 tracked investments · listed companies and verified rows first
Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.
BiotechMedical DevicesMorrisville, US
Karen Adams(Executive Officer)Stephen E. Butts(Executive Officer)
Co-investorsOrlando Health VenturesSolas BioVentures
Real-time asset tracking and workflow monitoring in healthcare
San Diego, US
Brandon Hull(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)Emily Wilson(Executive Officer)Paul Wallace(Director)inDana Mead(Director)
Co-investorsHeritage GroupIcon VenturesKleiner PerkinsNew Leaf Venture PartnersVenrock
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.
BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Vamsee Pamula(Executive Officer, Director)in
BoardDennis Sacha(Director)William A. Hawkins(Director)
Co-investorsCharlotte Angel FundDuke Capital PartnersIAG Capital PartnersSolas BioVenturesVentureSouthHG Ventures+1 more
BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.
Digital HealthHealthtechMedical DevicesSeattle, US
Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)
Co-investorsAPERTURE Venture PartnersAphelion CapitalAscension VenturesLumira VenturesRC CapitalSV Health Investors+2 more
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.
Austin, US
John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)
Co-investorsLouisiana FundsOrlando Health Ventures
Unable to determine company information; page contains only placeholder Lorem ipsum text.
AI & Machine LearningDigital HealthHealthtechPittsburgh, US
Gilan El Saadawi(Executive Officer, Director, Promoter)Betsy Castillo(Head of Clinical Data Abstraction)inMichael Finke(Director)Brenton Burns(Director)Scot Stevens(Director)Aaron Brauser(Executive Officer, Director, Promoter)
Co-investorsAsset Management CompanyCU Healthcare Innovation FundFrist Cressey VenturesHealthy VenturesKatalyst VenturesKatalyst.Ventures+10 more
Censinet provides risk management solutions for healthcare organizations, built by former healthcare operators and security experts who understand the integrated risks healthcare systems face.
CybersecurityEnterprise SoftwareHealthtechSaaSBoston, US
Ed Gaudet(Founder)inCambrey Warein
Co-investorsBallad VenturesExcelerate Health VenturesHLM Investment PartnersMemorialCare Innovation FundSchooner CapitalExcel Venture Management+1 more
CenTrak provides Real-Time Location System (RTLS) technology for healthcare facilities, including IoT wearables, infrastructure devices, software, and integrations with systems like EMR, CMMS, and Nurse Call.
HealthtechIoTMedical Devices
Co-investorsIcon Ventures
Emergo Therapeutics develops drugs designed to modulate inflammatory responses by reducing the production and secretion of inflammatory cytokines, targeting damaging symptoms across a range of diseases.
BiotechHealthtechDurham, US
Robin Hyde-DeRuyscher(Founder)inMoise Khayrallah(CEO)inMargaret Powell(Director)Robert Helmedag(Director)John E. Bailey, Jr.(Director)
Co-investorsWolfpack Investor NetworkHatteras Venture PartnersVentureSouth
HealthtechLos Altos, US
Siddarth Satish(Executive Officer, Director)Milton B. McColl(Executive Officer, Director)inRalph L. Arnheim III(Executive Officer)
BoardJay Watkins(Director)inMark Gonzalgo(Director)
Co-investorsCorewell Health VenturesGen CapitalPromus VenturesSonder CapitalSUMMATION HEALTH VENTURES
Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.
BiotechHealthtech
Co-investorsLongitude CapitalProspect Venture PartnersSolas BioVentures
Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.
AI & Machine LearningEnterprise SoftwareHealthtechWashington, US
Kevin MacDonald(Executive Officer)inTimothy Kress-Spatz(Executive Officer)
Co-investorsEaston CapitalKaiser Permanente VenturesLionBirdEaston Capital Investment GroupNew Leaf Venture PartnersRock Health+1 more
Leiters Health is an FDA-registered 503B outsourcing facility that produces sterile compounded preparations for hospitals, surgery centers, and ophthalmic use.
BiotechHealthtechMedical DevicesDenver, US
Co-investorsCorewell Health VenturesDementia Discovery FundEscalate Capital PartnersFrazier Healthcare PartnersH.I.G. CapitalH.I.G. HealthBridge Partners+4 more
Norwest is a venture and growth equity investment firm that has backed over 700 companies across biotech, life sciences, fintech, proptech, consumer products, and B2B SaaS, from early-stage through late-stage growth.
Sector Agnostic
Phononic develops solid-state cooling technology for data centers, focusing on thermal management solutions for critical infrastructure such as optical transceivers, GPUs, and AI accelerators.
AI & Machine LearningData & InfrastructureDeep TechEnergyHardwareDurham, US
Co-investorsATEL VenturesNotable CapitalOak Investment PartnersSQN Venture Partners, LLCTop Corner CapitalVenrock
symplr Directory centralizes and governs provider data across healthcare organizations, helping health plans and health systems maintain accurate, compliant provider information for credentialing, claims, and member-facing systems.
Digital HealthEnterprise SoftwareHealthtechSaaSDallas, US
Thomas White(Mr. White is the President of Phynd Technologies, Inc.)in
BoardJames Duda(Director)Peter White(Director)
Co-investorsFirst Trust Capital PartnersGreen Park & Golf VenturesInvest NebraskaBessemer Venture PartnersMemorialCare Innovation FundWellington Management
Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients.
Digital HealthHealthtechMedical DevicesMilford, US
Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)inMark Pacyna(Executive Officer, Director)inJim Dillon(Executive Officer, Director)Hanson S. Gifford III(Director)Gregory W Mann(Executive Officer)
Co-investorsArboretum VenturesLightstone VenturesDeerfield Management CompanyGenesis Venture CapitalSante Ventures
Symplr provides an operations platform that consolidates workforce, provider, quality, and financial management workflows for healthcare systems.
Digital HealthEnterprise SoftwareHealthtechSaaS
Co-investorsAdams Street PartnersBain Capital VenturesCharlesbank Capital PartnersFirst Trust Capital PartnersFrancisco Partners
HealthtechChapel Hill, US
Margaret Powell(Executive Officer, Director, Promoter)Michael Fried(Executive Officer, Director, Promoter)
BoardMoise Khayrallah(Director)in
Thoma Bravo is a software-focused private equity investment firm that acquires and invests in enterprise software and technology companies.
CybersecurityEnterprise SoftwareSaaS
Orlando Bravo(Founder and Managing Partner)inCarl D. Thoma(Founder and Managing Partner)in
Co-investorsRiverwood Capital
St.
HealthtechSt. Louis, US
Scott Wrightstone(Executive Officer)inMaureen Oehler(Executive Officer)Jason Pesterfield(Executive Officer, Director)inRyan Denney(Executive Officer)inMark Hunter(Executive Officer)inRobert Powers(Executive Officer)in
Co-investorsRC CapitalSolas BioVenturesAdvantage Capital PartnersProlog VenturesVensana CapitalVersant Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Aerial BioPharmaBio 54CorcymMidnight PharmaPryonRediscovery
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.